Coronary Syndrome, Acute, Non-ST Elevation, High Risk Patients
Cardiovascular
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
2028
2029
ME TherapeuticsRevascularization
Clinical Trials (1)
Management Tactics for Patients High Risk With Acute Coronary Syndrome Without ST Segment Elevation and Multivessel Coronary Artery Disease
Start: Feb 2024Est. completion: Dec 2029
N/ARecruiting
Related Jobs in Cardiovascular
Embedded Software and System Test Engineer (H/F)
Cardiawave
Levallois-Perret, France (Hybrid)
Just now
Territory Sales Manager - Iowa / Nebraska
HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
23h ago
From $150K/yr
Physician Program Director, Los Angeles
Johnson & Johnson
Danvers, Massachusetts, United States of America
Yesterday
$132K - $212K/yr
J&J MedTech Neurovascular Senior Financial Analyst, R&D
Johnson & Johnson
Irvine, California, United States of America
Yesterday
$79K - $128K/yr
Ingénieur d'Application Clinique (H/F) Dept. 54, 57, 67, 68, 25, 90
Johnson & Johnson
Issy-les-Moulineaux, France
Yesterday
Trainee Technical Specialist
Johnson & Johnson
Leeds, West Yorkshire, United Kingdom
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials
1 companies competing in this space